Alirocumab after Acute Coronary Syndrome
N Engl J Med
.
2019 May 23;380(21):2074-2075.
doi: 10.1056/NEJMc1902955.
Authors
Yuan Gao
1
,
Bing Hou
2
Affiliations
1
Beijing Youan Hospital, Beijing, China.
2
Xenorm MedInfo Center, Beijing, China hou_bing@hotmail.com.
PMID:
31116929
DOI:
10.1056/NEJMc1902955
No abstract available
Publication types
Letter
Comment
MeSH terms
Acute Coronary Syndrome*
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Humans
Proprotein Convertase 9
Substances
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Proprotein Convertase 9
alirocumab